Clinical Performance of Composites in Patients With Amelogenesis Imperfecta

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In AI patients, adhesion still remains the first option in order to achieve an early, minimally invasive intervention, and the altered enamel still represents an acceptable substrate for bonding in some AI variants. Many cases have revealed that the direct composite restorations provide satisfactory esthetic and functionality in restoring AI-affected teeth. The objective of this study was to evaluate the clinical performance of composite restorations in posterior teeth in patients afflicted with Amelogenesis Imperfecta using nanohybrid and nanofill composite materials

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Evaluation of Direct Composite Veneer Restorations

NCT05842590

Molar Incisor Hypomineralization

UNKNOWN NA

Clinical Performance of Posterior Indirect Adhesive Restorations

NCT04838483

Dental Caries Endodontically Treated Teeth Dental Restoration Failure of Marginal Integrity +1 more

UNKNOWN NA

Clinical Evaluation of Posterior Indirect Adhesive Restorations

NCT04293770

Dental Caries Endodontically Treated Teeth Dental Restoration Failure of Marginal Integrity +2 more

UNKNOWN NA

Clinical Comparison of CAD/CAM Nanohybrid Composite and Hybrid Ceramic Overlays in Children With Molar-Incisor Hypomineralisation

NCT06987448

Enamel Hypoplasia Molar-Incisor Hypomineralization (MIH) Restoration of Permanent Molars Affected by MIH With CAD/CAM Blocks

COMPLETED NA

Clinical Evaluation of Direct and Indirect Composites

NCT06667271

Dental Caries

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amelogenesis Imperfecta Dental Caries Dental Composite

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients have carious lesions in one or more surface of molars and premolars

patients received direct composite restorations using a nanohybrid and a nonofil composite restorations

Group Type OTHER

dental composite

Intervention Type OTHER

clinical performance of composite restorations used for posterior teeth in patients with Amelogenesis Imperfecta

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dental composite

clinical performance of composite restorations used for posterior teeth in patients with Amelogenesis Imperfecta

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* the patient had to require treatment due to carious lesions in one or more surface of molars and premolars,
* AI diagnosis had to be made, which had to be verified clinically, and also confirmed by anamnestic family history, or clinical examination concerning Witkop's classification

Exclusion Criteria

* patients with developmental enamel defects of other origins such as fluorosis, molar incisor hypomineralization;
* AI was associated with other oral developmental or systemic disorders, and dental abnormalities such as open-bite, deep-bite, and cross-bite;
* patients who were unable to provide their informed consent.

Minimum Eligible Age

14 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes